Junxi Lu
Impact in
- Nephrology top 2%
- Chronic Kidney Disease and Diabetes
-
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Diabetes Treatment and Management
Papers in
- Nephrology 21
- Chronic Kidney Disease and Diabetes 15
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 15
- Diabetes Treatment and Management 5
- Co-authors
- Weiping Jia (74 shared papers)Yuqian Bao (46 shared papers)Kun‐san Xiang (26 shared papers)Huijuan Lu (15 shared papers)Haibing Chen (22 shared papers)Haoyong Yu (18 shared papers)Fang Liu (7 shared papers)Kaifeng Guo (13 shared papers)
- Journals
- PLoS ONE (4 papers)Diabetology & Metabolic Syndrome (4 papers)Atherosclerosis (3 papers)Acta Pharmacologica Sinica (3 papers)Scientific Reports (3 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Junxi Lu
107 papers receiving 3.6k citations
Junxi Lu's Hit Papers
Peers
Comparison fields: 5 of 108
- Nephrology 378
- Endocrinology, Diabetes and Metabolism 641
- Rehabilitation 198
- Epidemiology 786
- Molecular Biology 778
Countries citing papers authored by Junxi Lu
This map shows the geographic impact of Junxi Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junxi Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junxi Lu more than expected).
Fields of papers citing papers by Junxi Lu
This network shows the impact of papers produced by Junxi Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junxi Lu. The network helps show where Junxi Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Junxi Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 108 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Exosomes derived from atorvastatin-pretreated MSC accelerate diabetic wound repair by enhancing angiogenesis via AKT/eNOS pathway Hit paper breakdown → | 2020 | 328 |
| 2 | 2008 | 193 | |
| 3 | 2021 | 180 | |
| 4 | 2006 | 172 | |
| 5 | 2011 | 149 | |
| 6 | 2007 | 119 | |
| 7 | 2009 | 100 | |
| 8 | 2020 | 96 | |
| 9 | 2021 | 93 | |
| 10 | 2015 | 89 | |
| 11 | Prediction of abdominal visceral obesity from body mass index, waist circumference and waist-hip ratio in Chinese adults: receiver operating characteristic curves analysis. | 2003 | 88 |
| 12 | 2016 | 74 | |
| 13 | 2007 | 66 | |
| 14 | 2016 | 65 | |
| 15 | 2020 | 65 | |
| 16 | 2015 | 63 | |
| 17 | 2008 | 56 | |
| 18 | 2019 | 56 | |
| 19 | 2022 | 53 | |
| 20 | 2014 | 52 |
About Junxi Lu
Junxi Lu is a scholar working on Nephrology, Endocrinology, Diabetes and Metabolism, Epidemiology, Genetics and Surgery, having authored 108 papers that have together received 3.7k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (16 papers), Chronic Kidney Disease and Diabetes (15 papers), Adipokines, Inflammation, and Metabolic Diseases (15 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (15 papers), Pancreatic function and diabetes (7 papers), Genetic Associations and Epidemiology (7 papers), Diabetes Treatment and Management (5 papers) and Diabetes and associated disorders (5 papers). The work is most often cited by research in Nephrology (378 citations), Endocrinology, Diabetes and Metabolism (641 citations), Rehabilitation (198 citations), Epidemiology (786 citations) and Molecular Biology (778 citations). Junxi Lu has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Weiping Jia, Yuqian Bao, Kun‐san Xiang, Huijuan Lu, Haibing Chen, Haoyong Yu, Fang Liu, Kaifeng Guo, Muyu Yu and Lianxi Li. Their work appears in journals such as PLoS ONE, Diabetology & Metabolic Syndrome, Atherosclerosis, Acta Pharmacologica Sinica and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.